Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary (2004)
Chapter: Appendix A: Agenda: Learning from SARS: Preparing for the Next Disease Outbreak
Appendix A
Learning from SARS: Preparing for the Next Disease Outbreak
September 30-October 1, 2003
SMITHSONIAN S. DILLON RIPLEY CENTER WASHINGTON, DC
AGENDA
TUESDAY, SEPTEMBER 30, 2003
|
8:30 |
Continental Breakfast |
|
9:00 |
Welcome and Opening Remarks Adel Mahmoud, M.D., Ph.D. Chair, Forum on Emerging Infections President, Merck Vaccines |
RECAPPING THE EVENTS: EXPERIENCES FROM THE FIELD
Session I: The Evolution of the Outbreak
Moderator: Harvey Fineberg, President, Institute of Medicine
|
9:15-9:40 |
CHINA: The Epicenter Yi Guan, M.D., Ph.D., The University of Hong Kong, Queen Mary Hospital |
|
9:40-10:00 |
Discussion |
|
10:00-10:25 |
SARS: Lessons from Toronto Don Low, M.D., FRCPC., Toronto Medical Laboratories, Mt. Sinai Hospital, Toronto |
|
10:25-10:45 |
Discussion |
|
10:45-11:10 |
WHO: The Global Response David Heymann, M.D., World Health Organization, Geneva |
|
11:10-11:30 |
Discussion |
|
11:30 |
BREAK |
Session II: Discussion Panel
Moderator: Stanley Lemon, M.D., Vice Chair, Forum on Emerging Infections/Dean of Medicine, The University of Texas Branch at Galveston
|
11:45 |
Discussants: |
Reporting Tools and Surveillance Networks: Ann-Marie Kimball, M.D., M.P.H., School of Public Health and Community Medicine, University of Washington International Coordination and Collaboration: Ray Arthur, Ph.D., National Center for Infectious Diseases, Global Health, CDC (Invited) Animal Coronaviruses—Lessons from SARS: Linda Saif, Ph.D., Ohio Agricultural Research Center, Ohio State University |
|
12:30 |
Open Discussion |
|
|
1:00 |
Lunch |
|
Session III: The Spectrum of Consequences and Responses
Moderator: James Hughes, M.D., NCID, CDC
|
2:00-2:25 |
Economic Impacts Warwick McKibbin, Ph.D., Australian National University |
|
2:25-2:45 |
Discussion |
|
2:45-3:10 |
The Implications of SARS Epidemic for China’s Public Health Infrastructure and Political System Yanzhong Huang, Ph.D., Seton Hall University, Whitehead School of Diplomacy and International Relations, Center for Global Health Studies |
|
3:10-3:30 |
Discussion |
|
3:30-3:55 |
Quarantine and Containment Strategies Marty Cetron, M.D., National Center for Infectious Diseases, CDC |
|
3:55-4:15 |
Discussion |
|
4:15-4:40 |
Impacts on Health Care Systems G. Neil Thomas, M.D., Department of Community Medicine, University of Hong Kong (Invited) |
|
4:40-5:00 |
Discussion |
Session IV: Open Discussion
|
5:00 |
Moderator: Joshua Lederberg, Ph.D., Nobel Laureate, Sackler Foundation Scholar, Rockefeller University |
|
Open Discussion |
|
|
6:00 |
Adjournment of the first day |
WEDNESDAY, OCTOBER 1, 2003
|
8:30 |
Continental Breakfast |
|
9:00 |
Opening Remarks/Summary of Day 1 Stanley Lemon, M.D. Vice Chair, Forum on Emerging Infections |
LEARNING FROM OUR LESSONS: THE AGENDA AHEAD
Session V: The Research Agenda and Emerging Technologies
Moderator: Carole Heilman Ph.D., Director, Division of Microbiology and Infectious Diseases, NIAID, NIH
|
9:15-9:40 |
Coronavirus Research Mark Denison, M.D., Vanderbilt University |
|
9:40-10:00 |
Discussion |
|
10:00-10:25 |
TIGER Technology for Emerging Infectious Disease Surveillance Ranga Sampath, Ph.D., Ibis Therapeutics, A Division of Isis Pharmaceuticals |
|
10:25-10:45 |
Discussion |
|
10:45-11:20 |
Pharmaceutical Approaches to Antiviral Drug Development Amy Patick, Ph.D. and Peter Dragovich, Ph.D., Pfizer Inc. |
|
11:20-11:30 |
Discussion |
|
11:30 |
BREAK |
|
11:45-12:10 |
Vaccines: Can We Prevent the Unexpected? Alan Shaw, Ph.D., Merck Research Laboratories |
|
12:10-12:30 |
Discussion |
|
12:30-12:50 |
SARS: Clearing the Air Jerome Schentag, Pharm.D., State University of New York-Buffalo |
|
12:50-1:00 |
Discussion |
|
1:00 |
LUNCH |
Session VI: Panel Discussion—Preparing for the Next Disease Outbreak
Moderator: Frederick Sparling, M.D., Professor of Medicine, Microbiology, and Immunology, University of North Carolina
|
2:00 |
Discussants: |
The Quest to Define and Control SARS: Robert Breiman, M.D., Centre for Health and Population Research, Dhaka, Bangladesh Regulatory Laboratory Planning/Preparedness: Kathryn Carbone, M.D., Center for Biologics, Food and Drug Administration Future Threats Assessment: Karen Monaghan, NIC, National Intelligence Council Report Public Health Law: Gene Matthews, J.D., Legal Advisor to CDC Modeling a Response Strategy: Nathaniel Hupert, M.D., M.P.H., Weill Cornell Medical College Face to Face w/Influenza: Robert Webster, Ph.D., St. Jude Children’s Research Hospital |
|
3:30 |
Open Discussion |
|
|
5:00 |
Closing Remarks/Adjourn |
|
